Thomas Jefferson University

Main menu:

Technologies Available for Licensing

    Diagnostics    |    Therapeutics    |    Devices    |    Drug Discovery    |    Other

        Therapeutics

Case Number Title Non-Confidential Summary Issued Patent Lead Inventor's Website
BER_ERI.001 Use of Tempol in the Prevention of Photoaging   [US Patent No. 5,840,734]
     
 
CRO_CAR.002 Compositions, Kits and Methods Relating to the Human FEZ1 Gene, a Novel Tumor Suppressor Gene NCS for Croce tumor suppressor techs (CRO_CAR.002, 004, 005, 016) [US Patent No. 7,141,417]
[US Patent No. 7,777,005]
   
 
CRO_CAR.004 The Human FHIT Gene NCS for Croce tumor suppressor techs (CRO 2,4,5,16) [United States Patent: 7220834]
[United States Patent: 6774217]
[United States Patent: 6242212]
[United States Patent: 5928884]
 
CRO_CAR.009 TCL-1 Gene And Protein And Related Methods And Compositions NCS for Croce TCL-1 techs (CRO_CAR.009, 015) [US Patent No. 5,985,598]
[US Patent No. 7,175,995]
[US Patent No. 7,749,715]
 
 
CRO_CAR.015 Human Chronic Lymphocytic Leukemia Modeled in Mouse by Targeted TCL1 Expression NCS for Croce TCL-1 techs (CRO_CAR.009,015) [US Patent No. 7,728,189]
[US Patent No. 8,168,854]
   
 
CRO_CAR.016 Novel Tumor Suppressor Gene and Compositions and Methods for Making and Using the Same NCS for Croce tumor suppressor techs (CRO 2,4,5,16)          
CRO_CAR.017 Role of microRNA Genes In Human Cancer NCS for Croce miRNA techs (CRO 17, 25) [US Patent No 7,723,035]
[US Patent App 12/319,331]
[US Patent App 12/727,778]
 
 
CRO_CAR.019 Involvement Of The ALL-1 Gene In A Solid Tumor1   [US Patent No. 5,567,586]
     
 
CRO_CAR.025 microRNA genes in cancer diagnosis and treatment NCS for Croce miRNA techs (CRO 17, 25) [US Patent No 7,723,030]
[US Patent App 12/751,463]
[US Patent App 12/767,279]
 
 
DIE_BER.010 Recombinant Rabies for Pre- and Post-Exposure Prophylaxis           Link
DIE_BER.012 A Method to Modulate and Enhance the Immune Response through Prime/Boost Immunization T:\NCS's For OTT Website ONLY\NCS for DIE_BER.012.pdf         Link
DUR_MAT.005 Insulin And Insulin-Associated Peptides For Cerebral Health T:\NCS's For OTT Website ONLY\NCS for DUR_MAT.005.pdf          
FER_AND.002 Antibody-based Inhibitors of Excessive Deposition of Fibrotic Tissue NCS for FER_AND.002         Link
HOU_YAM.005 Apoptosis of Cardiomyocytes           Link
HOU_YAM.006 Antibiotics Targeting a Growth-Dependent Bacterial Enzyme           Link
IOZ_REN.001 A Role For Decorin In Tumor Suppression   [US Patent No. 6,524,573]
     
Link
KAS_DAV.001 A Small Bowel Purgative for Wireless Capsule Endoscopy NCS for KAS_DAV.001          
KOP_HIL.006 Polypeptides Fused with Alfalfa Mosaic Virus or Ilarvirus Capsid Proteins   [US Patent No. 6,042,832]
[US Patent No. 6,448,070]
   
 
MEN_SUE.004 Method for Treatment of PCO           Link
PEZ_TIF.001H Secretion Free Continuous Nebulizer NCS for PEZ_TIF.001H          
PRI_EDM.005 A Pocketsized Medical Auto-Injector NCS for PRI_EDM.005         Link
RAB_JOS.001 Development of an Enhancer/Promoter Pair for Heart Selective Gene Expression NCS for RAB_JOS.001          
SAN_JAM.001 Peptides with High Affinity for Heparin and for Proteoglycans to be used to Promote Endothelialization of Synthetic Vascular Graft Surfaces, or to Target the Delivery of Drugs to Cell Surfaces NCS for SAN_JAM.001, .002 [US Patent No. 6,855,801]
     
 
SAN_JAM.002 Peptides that Neutralize Heparin or Proteoglycans, or Promote Cell Adhesion or Drug Delivery NCS for SAN_JAM.001, .002 [US Patent No. 7,259,140]
     
 
SCH_JAY.001 Treatment of Parkinson's Disease with Oligonucleotide and Triplex Technology NCS for SCH_JAY.001, 002, 004, 008         Link
SCH_JAY.002 Partial Agonists at the Glycine Modulatory Site of the NMDA Receptor for Treating Cognitive Dysfunction in Parkinson's Disease NCS for SCH_JAY.001, 002, 004, 008         Link
SCH_JAY.004 Method of Treating Parkinson's Disease and Composition for the Same NCS for SCH_JAY.001, 002, 004, 008 [United States Patent: 7160913]
     
Link
SCH_JAY.008 Treatment of Parkinson's Disease and Parkinson's Disease Treatment-related Complications with RNA Inhibition Therapies NCS for SCH_JAY.001, 002, 004, 008         Link
SHO_SUN.001 Pure Protein Nanoparticles for Drug Delivery NCS for SHO_SUN.001          
STR_DAV.001 SV40 Viral Vectors for Targeted Integration Into Cells   [US Patent No. 5,863,794]
     
Link
SUN_XIA.001 Implantable Sensor and System for Measurement and Control of Blood Constituent Levels   [US Patent No. 5,995,860]
[US Patent No. 6,122,536]
   
 
THO_JEF.001 Nitric Oxide Donor Compositions, Methods, Apparatus, and Kits for Alleviating Vasoconstriction and Vasospasm in a Mammal   [US Patent No. 6,358,536]
     
 
WIL_JOH.005 Design and Development of Masked Therapeutic Antibodies to Limit Off-Target Effects: Application to Anti-EGFR Antibodies (Also known as "EGFR-Specific ScFvs Engineered to Enable Selective Antigen Recognition Upon Proteolytic Activation")            
ZAL_AND.002 Inhibition of Extracellular Matrix Synthesis By Antisense Compounds Directed to Nuclear Proto-Oncogenes   [US Patent No. 6,133,242]
     
 
Click to leave feedback
feedback